Emerging Infectious Disease ISSN: 1080-6059

- Add this to...
- Favorites
- Del.icio.us
- Digg
- Facebook
- Google Bookmarks
- Yahoo MyWeb

bla_OXA-181–positive Klebsiella pneumoniae, Singapore

Tse H. Koh

, Delphine Y.H. Cao, Kian S. Chan, Limin Wijaya, Stewart B.G. Low, Mun S. Lam, Eng E. Ooi, and Li-Yang Hsu

Author affiliations: National University of Singapore, Singapore (T.H. Koh, L.-Y. Hsu); Singapore General Hospital, Singapore (T.H. Koh, D.Y.H. Cao, K.S. Chan, L. Wijaya); Mount Alvernia Hospital, Singapore (S.B.G. Low); Mount Elizabeth Medical Centre, Singapore (M.S. Lam); and Duke–National University of Singapore–Graduate Medical School, Singapore (E.E. Ooi)

Main Article

Table

Antimicrobial drug susceptibilities of 3 bla_OXA-181–positive Klebsiella pneumoniae isolates, Singapore*

Drug	MIC (mg/L)
Drug	DB53879_11	DX1083_11	BL21479_11
Ampicillin	≥256	≥256	≥256
Amoxicillin/clavulanate	≥256	≥256	≥256
Piperacillin/tazobactam	≥256	≥256	≥256
Cefuroxime	≥256	≥256	≥256
Ceftriaxone	≥32	≥32	≥32
Ceftazidime	≥256	≥256	≥256
Cefepime	≥256	≥256	≥256
Ertapenem	≥32	≥32	≥32
Imipenem	16	≥32	16
Meropenem	≥32	≥32	≥32
Doripenem	≥32	≥32	≥32
Ciprofloxacin	≥32	≥32	≥32
Levofloxacin	≥32	≥32	≥32
Gentamicin	≥256	≥256	≥256
Amikacin	≥256	≥256	≥256
Sulfamethoxazole/trimethoprim	≥32	≥32	≥32
Tetracycine	≥256	≥256	8
Tigecycline	4	4	4
Polymyxin B	0.5	1	4